Editas Medicine (EDIT) Net Margin Growth (5y) (2020 - 2025)
Editas Medicine (EDIT) Net Margin Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34,541.00 |
| Jun 30, 2025 | -123,297.00 |
| Mar 31, 2025 | -103,369.00 |
| Dec 31, 2024 | 15,849.00 |
| Sep 30, 2024 | -10.10 Mn |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | -438,394.00 |
| Dec 31, 2023 | 37,250.00 |
| Sep 30, 2023 | -238,416.00 |
| Jun 30, 2023 | -1.70 Mn |
| Mar 31, 2023 | -209,466.00 |
| Dec 31, 2022 | -47,409.00 |
| Sep 30, 2022 | -378.51 Mn |
| Jun 30, 2022 | -1.59 Mn |
| Mar 31, 2022 | -5.46 Mn |
| Dec 31, 2021 | 411,445.00 |
| Sep 30, 2021 | 109,579.00 |
| Jun 30, 2021 | -3.39 Mn |
| Mar 31, 2021 | 66,998.00 |
| Dec 31, 2020 | 106,025.00 |